UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linear β-1,3 Glucans Are Elicitors of Defense Responses in Tobacco

Plant physiology (Bethesda), 2000-11, Vol.124 (3), p.1027-1037

2000

Volltextzugriff (PDF)

Sulfated fucan oligosaccharides elicit defense responses in tobacco and local and systemic resistance against tobacco mosaic virus

Molecular plant-microbe interactions, 2003-02, Vol.16 (2), p.115-122

2003

Volltextzugriff (PDF)

Structure and promoter activity of a stress and developmentally regulated polyubiquitin-encoding gene of Nicotiana tabacum

Gene, 1994-10, Vol.148 (2), p.195-202

1994

Volltextzugriff (PDF)

Effects of the polyubiquitin gene Ubi. U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum

Plant molecular biology, 2001-04, Vol.45 (6), p.655

2001

Volltextzugriff (PDF)

Effects of the polyubiquitin gene Ubi.U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum

Plant molecular biology, 2001-04, Vol.45 (6), p.655-667

2001

Volltextzugriff (PDF)

Why are quiescent mesophyll protoplasts from Nicotiana sylvestris able to re-enter into the cell cycle and re-initiate a mitotic activity?

Biochimie, 1993, Vol.75 (7), p.539-545

1993

Volltextzugriff (PDF)

Linear beta -1,3 Glucans Are Elicitors of Defense Responses in Tobacco

Plant physiology (Bethesda), 2000-11, Vol.124 (3), p.1039-1048

2000

Volltextzugriff (PDF)

Identification of a new cis-regulatory element in a Nicotiana tabacum polyubiquitin gene promoter

Molecular & general genetics, 1997-04, Vol.254 (3), p.258-266

1997

Volltextzugriff (PDF)

Characterization of genes expressed in mesophyll protoplasts of Nicotiana sylvestris before the re-initiation of the DNA replicational activity

Mechanisms of development, 1992-08, Vol.38 (2), p.121-132

1992

Volltextzugriff (PDF)

Laser-assisted lead extraction: the European experience

Europace (London, England), 2007-08, Vol.9 (8), p.651-656

2007

Volltextzugriff (PDF)

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Annals of oncology, 2023-08, Vol.34 (8), p.681-692

2023

Volltextzugriff (PDF)

4D smart porous scaffolds based on the polyHIPE architecture and electroactive PEDOT

Journal of materials chemistry. C, Materials for optical and electronic devices, 2021-09, Vol.9 (36), p.12388-12398

2021

Volltextzugriff (PDF)

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

The New England journal of medicine, 2012-07, Vol.367 (2), p.107-114

2012

Volltextzugriff (PDF)

1672P Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

Annals of oncology, 2021-09, Vol.32, p.S1175-S1175

2021

Volltextzugriff (PDF)

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

ESMO open, 2021-06, Vol.6 (3), p.100150-100150, Article 100150

2021

Volltextzugriff (PDF)

176O Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Annals of oncology, 2022-11, Vol.33, p.S1503-S1504

2022

Volltextzugriff (PDF)

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Annals of oncology, 2022-09, Vol.33, p.S1396-S1397

2022

Volltextzugriff (PDF)

Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

Annals of oncology, 2021, Vol.32 (5)

2021

Volltextzugriff (PDF)

102P Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases: Characteristics and validation of prognostic models in a large real-life database

Annals of oncology, 2021-05, Vol.32, p.S67

2021

Volltextzugriff (PDF)

823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study

Annals of oncology, 2020-09, Vol.31, p.S621-S622

2020

Volltextzugriff (PDF)

Abstract P3-14-03: PRESAGE : Prospective multicenter feasibility study of fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Preliminary results

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-14-03

2018

Volltextzugriff (PDF)

High diagnostic accuracy of the detection of atrial arrhythmias from smartwatch electrocardiograms using a deep neural network

Archives of cardiovascular diseases supplements, 2023-01, Vol.15 (1), p.172

2023

Volltextzugriff (PDF)

LBA2_PRPhase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract P5-20-03: Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcome in 2863 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-20-03

2018

Volltextzugriff (PDF)

Abstract P4-16-02: Fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Final results of PRESAGE trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-16-02

2019

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(11)
Female
(8)
Humans
(8)
Plants, Toxic
(6)
Biological And Medical Sciences
(5)
Gene Expression
(5)
Nicotiana - Genetics
(5)
Fundamental And Applied Biological Sciences. Psychology
(4)
Genes, Plant
(4)
Molecular Sequence Data
(4)
Nicotiana Tabacum
(4)
Pregnancy
(4)
Adult
(3)
Aged
(3)
Amino Acid Sequence
(3)
Base Sequence
(3)
Biochemistry & Molecular Biology
(3)
Biopolymers - Genetics
(3)
Cells, Cultured
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linear β-1,3 Glucans Are Elicitors of Defense Responses in Tobacco

Sulfated fucan oligosaccharides elicit defense responses in tobacco and local and systemic resistance against tobacco mosaic virus

Structure and promoter activity of a stress and developmentally regulated polyubiquitin-encoding gene of Nicotiana tabacum

Effects of the polyubiquitin gene Ubi. U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum

Effects of the polyubiquitin gene Ubi.U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum

Why are quiescent mesophyll protoplasts from Nicotiana sylvestris able to re-enter into the cell cycle and re-initiate a mitotic activity?

Linear beta -1,3 Glucans Are Elicitors of Defense Responses in Tobacco

Identification of a new cis-regulatory element in a Nicotiana tabacum polyubiquitin gene promoter

Characterization of genes expressed in mesophyll protoplasts of Nicotiana sylvestris before the re-initiation of the DNA replicational activity

Laser-assisted lead extraction: the European experience

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

4D smart porous scaffolds based on the polyHIPE architecture and electroactive PEDOT

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

1672P Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

176O Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

102P Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases: Characteristics and validation of prognostic models in a large real-life database

823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study

Abstract P3-14-03: PRESAGE : Prospective multicenter feasibility study of fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Preliminary results

High diagnostic accuracy of the detection of atrial arrhythmias from smartwatch electrocardiograms using a deep neural network

LBA2_PRPhase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

Abstract P5-20-03: Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcome in 2863 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program

Abstract P4-16-02: Fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Final results of PRESAGE trial

Suchergebnisse filtern